Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy
Jornal de Pediatria · 2026-07 · 102 (4) · 101552
DOI: 10.1016/j.jped.2026.101552 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jornal de Pediatria, 2026-07. Verfasst von Gabriel Cezar Dos Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Graduate Program in Child and Adolescent Health, Campinas, SP, Braz…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Abdominal Pain, Inflammation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, State University of Campinas Teaching Research and Extension Support Fund, Universidade Estadual de Campinas.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Cystic fibrosis (CF) is a rare genetic disease caused by mutations in the CFTR gene, resulting in a dysfunctional protein that affects various systems in the body, including the gastrointestinal (GI) tract. The changes caused by CF in the GI tract include dysmotility, dysbiosis, intestinal inflammation, and abdominal symptoms such as pain, altered bowel habits, and distension, which are frequent in people with CF. This study aims to establish the prevalence of these complaints in children with CF and investigate associations between symptoms, clinical conditions, and markers of intestinal inflammation.
Methods
Twenty-two pediatric patients with a genetic diagnosis of CF, followed at a Brazilian reference center, were included. Methods involved a systematic assessment of gastrointestinal symptoms using a questionnaire, biochemical analysis of fecal calprotectin (FC) as a marker of intestinal inflammation, and collection of clinical, anthropometric, laboratory, and imaging data from medical records.
Results
86.3% (n = 19) of participants showed elevated FC levels (> 50 gt; 50 mcg/g), indicating a high prevalence of intestinal inflammation. The most common abdominal symptoms were pain and flatulence, present in about half of the patients. No significant associations were observed between FC levels and clinical or symptomatic variables.
Conclusion
There is a high prevalence of intestinal inflammation and abdominal symptoms in this sample of Brazilian children with CF, highlighting the importance of systematically investigating these symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Graduate Program in Child and Adolescent Health, Campinas, SP, Brazil. Electronic address: gabrielcezar.unicamp@gmail.com.
- Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Graduate Program in Child and Adolescent Health, Campinas, SP, Brazil.
- Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Surgery Department, Gastrocenter, Colorectal Surgery Unit, Inflammatory Bowel Disease Research Laboratory (LABDII), Campinas, SP, Brazil.
- Universidade Estadual de Campinas (UNICAMP), Faculdade de Ciências Médicas (FCM), Department of Pediatrics, Campinas, SP, Brazil.
Förderung
- National Council for Scientific and Technological Development
- State University of Campinas Teaching Research and Extension Support Fund
- Universidade Estadual de Campinas
Zitieren
APA
Dos Santos, G. C., Montera, L. C., Genaro, L. M., Rodrigues, B. A. G., Leal, R. F., Ribeiro, A. F., Ribeiro, J. D., & Lomazi, E. A. (2026). Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy. Jornal de Pediatria, 102(4), 101552. https://doi.org/10.1016/j.jped.2026.101552
Vancouver
Dos Santos GC, Montera LC, Genaro LM, Rodrigues BAG, Leal RF, Ribeiro AF, et al. Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy. Jornal de Pediatria. 2026;102(4):101552. doi:10.1016/j.jped.2026.101552
BibTeX
@article{DosSantos2026,
author = {Dos Santos, Gabriel Cezar and Montera, Lorenna Cristina and Genaro, Lívia Moreira and Rodrigues, Beatriz Alves Guerra and Leal, Raquel Franco and Ribeiro, Antonio Fernando and Ribeiro, Jose Dirceu and Lomazi, Elizete Aparecida},
title = {Assessment of abdominal symptoms and intestinal inflammation in children and adolescents with cystic fibrosis without highly effective modulator therapy},
journal = {Jornal de Pediatria},
year = {2026},
volume = {102},
number = {4},
pages = {101552},
doi = {10.1016/j.jped.2026.101552}
}
EUVIMED